MedPath

Evaluating MMPs in Burns

Terminated
Conditions
Burns
Thermal Injury
Thermal Burn
Interventions
Procedure: Graft
Registration Number
NCT03148977
Lead Sponsor
University of Florida
Brief Summary

The objective of this study is to determine whether our chemical assay can be used to reliably predict graft take or failure in patients undergoing autologous skin grafting for treatment of acute burn injury.

Detailed Description

This is an observational pilot study of patients treated at UF Health Shands Burn Center adult service. This is a study to determine the predictive value of quantifying concentrations of specific MMPs. Coupling this with a specialized collection sample collection system and a calibrated fluorimetry allows for the rapid assessment of MMP concentrations. This assay has been validated as a predictor of failed wound healing in a published clinical study involving chronic open wounds.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • 18 years of age or older
  • Admitted with acute burns injuries (flame, contact or scald) requiring at least one surgical excision and grafting operation will be considered for inclusion
  • Burn injury less than one week old
Read More
Exclusion Criteria
  • Electrical, chemical or cold-induced burn injury
  • Total body surface area burn >50 %
  • Pre injury diagnosis of chronic renal insufficiency, liver failure, refusal to accept blood transfusion or withdrawal of care within three days of admission will also be exclusion criteria
  • Patients not expected to survive
  • Patients presenting with re-injury to previously burned and treated areas.
  • Patients who present after receiving burn excision surgery out an outside facility for the current acute injury
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients admitted to the burn centerGraftPatients admitted to the Burn Service with acute burn injuries requiring at least one surgical excision and grafting operation.
Primary Outcome Measures
NameTimeMethod
Predictability of graft take2 years

Determine whether chemical assay can be used to reliably predict graft take or failure in patients undergoing autologous skin grafting for treatment of acute burn injury.

Secondary Outcome Measures
NameTimeMethod
Wound healing2 years

Assess the predictive value of serial MMP assays in identifying wounds transitioning from likely-to-fail to likely-to-succeed

Trial Locations

Locations (2)

UF Health Shands at the University of Florida

🇺🇸

Gainesville, Florida, United States

UF Health Cancer Hospital

🇺🇸

Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath